CA2690737A1 - 6.5-pyrrolopiperidine tachykinin receptor antagonists - Google Patents

6.5-pyrrolopiperidine tachykinin receptor antagonists Download PDF

Info

Publication number
CA2690737A1
CA2690737A1 CA2690737A CA2690737A CA2690737A1 CA 2690737 A1 CA2690737 A1 CA 2690737A1 CA 2690737 A CA2690737 A CA 2690737A CA 2690737 A CA2690737 A CA 2690737A CA 2690737 A1 CA2690737 A1 CA 2690737A1
Authority
CA
Canada
Prior art keywords
compound
group
hydrogen
6alkyl
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2690737A
Other languages
English (en)
French (fr)
Inventor
Jianming Bao
Robert J. Devita
Huagang Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2690737A1 publication Critical patent/CA2690737A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2690737A 2007-06-22 2008-06-18 6.5-pyrrolopiperidine tachykinin receptor antagonists Abandoned CA2690737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93686407P 2007-06-22 2007-06-22
US60/936,864 2007-06-22
PCT/US2008/067270 WO2009002770A1 (en) 2007-06-22 2008-06-18 6.5-pyrrolopiperidine tachykinin receptor antagonists

Publications (1)

Publication Number Publication Date
CA2690737A1 true CA2690737A1 (en) 2008-12-31

Family

ID=40185984

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2690737A Abandoned CA2690737A1 (en) 2007-06-22 2008-06-18 6.5-pyrrolopiperidine tachykinin receptor antagonists

Country Status (5)

Country Link
EP (1) EP2170064A4 (ja)
JP (1) JP2010530874A (ja)
AU (1) AU2008268667A1 (ja)
CA (1) CA2690737A1 (ja)
WO (1) WO2009002770A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101074202B1 (ko) * 2007-01-18 2011-10-14 에스케이종합화학 주식회사 에틸렌 사량체화 촉매계 및 이를 이용한 1-옥텐의 제조방법
RS56634B1 (sr) 2009-11-20 2018-03-30 Tonix Pharma Holdings Ltd Postupci i kompozicije za lečenje simptoma povezanih sa posttraumatskim stresnim poremećajem korišćenjem ciklobenzaprina
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
ES2672099T3 (es) 2011-07-04 2018-06-12 Irbm - Science Park S.P.A. Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
RU2631319C2 (ru) 2012-02-22 2017-09-21 Лео Фарма А/С Новые соединения - антагонисты рецептора нейрокинина 1
AR092211A1 (es) * 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung Derivados de hidropirrolopirrol
ES2769879T3 (es) 2013-03-15 2020-06-29 Tonix Pharma Holdings Ltd Formulaciones eutécticas de clorhidrato de ciclobenzaprina y manitol
WO2015024203A1 (en) * 2013-08-20 2015-02-26 Leo Pharma A/S Novel neurokinin 1 receptor antagonist compounds ii
CN105579456A (zh) * 2013-08-20 2016-05-11 利奥制药有限公司 新型神经激肽1受体拮抗剂化合物ii
CA2961822A1 (en) 2014-09-18 2016-03-24 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride
BR112020011345A2 (pt) 2017-12-11 2020-11-17 Tonix Pharma Holdings Limited tratamento com ciclobenzaprina para agitação, psicose e declínio cognitivo na demência e condições neurodegenerativas
AU2019223237A1 (en) 2018-02-26 2020-09-03 Ospedale San Raffaele S.R.L. NK-1 antagonists for use in the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
EP1638935A1 (en) * 2003-06-19 2006-03-29 Pfizer Products Inc. Nk1 antagonist
AU2005316676A1 (en) * 2004-12-14 2006-06-22 Merck & Co., Inc. Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists

Also Published As

Publication number Publication date
EP2170064A4 (en) 2010-08-04
JP2010530874A (ja) 2010-09-16
AU2008268667A1 (en) 2008-12-31
WO2009002770A1 (en) 2008-12-31
EP2170064A1 (en) 2010-04-07

Similar Documents

Publication Publication Date Title
CA2690737A1 (en) 6.5-pyrrolopiperidine tachykinin receptor antagonists
EP1711465B1 (en) Hydroisoindoline tachykinin receptor antagonists
EP1819342A1 (en) Quinoline tachykinin receptor antagonists
US7652058B2 (en) Octahydropyrano[3,4-C]pyrrole tachykinin receptor antagonists
US20080039494A1 (en) 8-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists
AU2008236639B2 (en) Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists
US20090221611A1 (en) Fused Triazole Tachykinin Receptor Antagonists
US20080076783A1 (en) Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists
US20090048248A1 (en) Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists
US20080146588A1 (en) Piperidinyl Piperidine Tachykinin Receptor Antagonists
US20080009518A1 (en) 5-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists
US20100197724A1 (en) 6.5 -pyrrolopiperidine tachykinin receptor antagonists
US20080153851A1 (en) Cycloalkyl Piperidine Tachykinin Receptor Antagonists
US20090042854A1 (en) Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists

Legal Events

Date Code Title Description
FZDE Dead